Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma
Clinical trial NCT05978050 · RECRUITING
Trial details
- NCT number
- NCT05978050
- Sponsor
- Biotech Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-01
- Primary completion
- 2026-03-01
- Enrollment
- 354
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.